The 1 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 1.80, with a high estimate of 1.80 and a low estimate of 1.80. The median estimate represents a +4,037.93% increase from the last price of 0.04.
The current consensus among 1 polled investment analysts is to Buy stock in Evofem Biosciences Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.25
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.